Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -30.74% is 69% above its 5-year average of -98.82%, near the high end of its 5-year range (-574.91%–-30.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 58.88% above its 12-month average of -74.75%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -30.74%.
RETURN ON EQUITY (ROE)
-30.74%
RETURN ON EQUITY (ROE) AVG TTM
-74.75%
RETURN ON EQUITY (ROE) AVG 3Y
-183.51%
RETURN ON EQUITY (ROE) AVG 5Y
-98.82%
RETURN ON EQUITY (ROE) AVG 10Y
-53.75%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+58.88%
CURRENT VS 3Y AVG
+83.25%
CURRENT VS 5Y AVG
+68.89%
CURRENT VS 10Y AVG
+42.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 533 covered companies
CURRENT VS SECTOR MEDIAN
+23.53%
vs the sector median at left
Bio Green Med Solution, Inc.
Market Cap
$4.83M
Return on Equity (ROE)
-30.74%
TTM Avg
-74.75%
3Y Avg
-183.51%
5Y Avg
-98.82%
Market Cap
$4.73M
Return on Equity (ROE)
-163.18%
TTM Avg
-235.11%
3Y Avg
-195.15%
5Y Avg
-161.13%
Market Cap
$5.01M
Return on Equity (ROE)
-248.66%
TTM Avg
-110.63%
3Y Avg
-33.84%
5Y Avg
-33.84%
Market Cap
$4.63M
Return on Equity (ROE)
-385.27%
TTM Avg
175.03%
3Y Avg
3.40%
5Y Avg
-11.76%
Market Cap
$5.09M
Return on Equity (ROE)
-42.05%
TTM Avg
-32.76%
3Y Avg
-25.11%
5Y Avg
-45.26%
Market Cap
$5.11M
Return on Equity (ROE)
-351.30%
TTM Avg
-321.98%
3Y Avg
-228.03%
5Y Avg
-177.46%
Market Cap
$4.55M
Return on Equity (ROE)
-239.95%
TTM Avg
-454.28%
3Y Avg
-297.70%
5Y Avg
-194.53%
Market Cap
$5.19M
Return on Equity (ROE)
N/A
TTM Avg
383.38%
3Y Avg
131.31%
5Y Avg
101.98%
Market Cap
$5.20M
Return on Equity (ROE)
-4165.92%
TTM Avg
61.14%
3Y Avg
-23.12%
5Y Avg
-18.15%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio Green Med Solution, Inc. (BGMS) | $4.83M | -30.74% | -74.75% | -183.51% | -98.82% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.73M | -163.18% | -235.11% | -195.15% | -161.13% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -248.66% | -110.63% | -33.84% | -33.84% |
| CalciMedica, Inc. (CALC)vs › | $4.63M | -385.27% | 175.03% | 3.40% | -11.76% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.09M | -42.05% | -32.76% | -25.11% | -45.26% |
| Imunon, Inc. (IMNN)vs › | $5.11M | -351.30% | -321.98% | -228.03% | -177.46% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.55M | -239.95% | -454.28% | -297.70% | -194.53% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | N/A | 383.38% | 131.31% | 101.98% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.20M | -4165.92% | 61.14% | -23.12% | -18.15% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.21M | -225.57% | -289.16% | -245.03% | -192.04% |
ROE
-30.7%
ROA
-28.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -30.74% |
| 2026-03-31 | -46.07% |
| 2025-12-31 | -43.82% |
| 2025-09-30 | -76.65% |
| 2025-06-30 | -176.48% |
| 2025-03-31 | -272.60% |
| 2023-09-30 | -574.91% |
| 2023-06-30 | -246.81% |
| 2023-03-31 | -156.37% |
| 2022-12-31 | -103.75% |
| 2022-09-30 | -86.43% |
| 2022-06-30 | -62.78% |
| 2022-03-31 | -58.41% |
| 2021-12-31 | -50.10% |
| 2021-09-30 | -39.64% |
| 2021-06-30 | -31.62% |
| 2021-03-31 | -22.28% |
| 2020-12-31 | -25.39% |
| 2020-09-30 | -32.52% |
| 2020-06-30 | -28.56% |
| 2020-03-31 | -69.38% |
| 2019-12-31 | -66.95% |
| 2019-09-30 | -54.46% |
| 2019-06-30 | -49.02% |
| 2019-03-31 | -44.32% |
| 2018-12-31 | -47.71% |
| 2018-09-30 | -43.02% |
| 2018-06-30 | -37.20% |
| 2018-03-31 | -35.62% |
| 2017-12-31 | -34.32% |
| 2017-09-30 | -35.97% |
| 2017-06-30 | -81.88% |
| 2017-03-31 | -80.39% |
| 2016-12-31 | -82.61% |
| 2016-09-30 | -72.76% |
| 2016-06-30 | -91.85% |
| 2016-03-31 | -78.44% |
| 2015-12-31 | -76.15% |
| 2015-09-30 | -73.00% |
